Circulating microRNA-30d is associated with response to cardiac resynchronization therapy in heart failure and regulates cardiomyocyte apoptosis: A translational pilot study

Circulation

Volumn 131, Issue 25, 2015, Pages 2202-2216

  Melman, Yonathan F ^a   Shah, Ravi ^a,b   Danielson, Kirsty ^a   Xiao, Junjie ^c   Simonson, Bridget ^a   Barth, Andreas ^d   Chakir, Khalid ^d   Lewis, Gregory D ^b   Lavender, Zachary ^b   Truong, Quynh A ^b   Kleber, Andre ^a   Das, Ranendra ^d   Rosenzweig, Anthony ^a   Wang, Yaoyu ^e   Kass, David A ^d   Singh, Jagmeet P ^b   Das, Saumya ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c SHANGHAI UNIVERSITY   (China)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Biological markers; Heart failure; MicroRNAs; Stress biological

Indexed keywords

MICRORNA; MICRORNA 30D; MITOGEN ACTIVATED PROTEIN KINASE; TROPONIN T; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; MIRN30 MICRORNA, HUMAN;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CARDIAC RESYNCHRONIZATION THERAPY; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY SINUS BLOOD FLOW; FEMALE; HEART CONTRACTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CELL; HUMAN; MALE; MECHANICAL STRESS; NEWBORN; NONHUMAN; PILOT STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVIEW; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; ANIMAL; BLOOD; CARDIAC MUSCLE CELL; DOG; MIDDLE AGED; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BIOMARKERS; CARDIAC RESYNCHRONIZATION THERAPY; DOGS; FEMALE; HEART FAILURE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCYTES, CARDIAC; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY; TRANSLATIONAL MEDICAL RESEARCH; TREATMENT OUTCOME;

EID: 84935518485     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.013220     Document Type: Review

References (35)

1. Kass DA. An epidemic of dyssynchrony: But what does it mean? J Am Coll Cardiol. 2008;51: 12-17. doi: 10.1016/j.jacc.2007.09.027.
2. Vaillant C, Martins RP, Donal E, Leclercq C, Thébault C, Behar N, Mabo P, Daubert JC. Resolution of left bundle branch block-induced cardiomyopathy by cardiac resynchronization therapy. J Am Coll Cardiol. 2013;61: 1089-1095. doi: 10.1016/j.jacc.2012.10.053.
3. Kass DA. Ventricular resynchronization: Pathophysiology and identification of responders. Rev Cardiovasc Med. 2003;4(suppl 2): S3-S13.
4. Goldenberg I, Hall WJ, Beck CA, Moss AJ, Barsheshet A, McNitt S, Polonsky S, Brown MW, Zareba W. Reduction of the risk of recurring heart failure events with cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). J Am Coll Cardiol. 2011;58: 729-737. doi: 10.1016/j.jacc.2011.04.024.
5. Barsheshet A, Goldenberg I, Moss AJ, Eldar M, Huang DT, McNitt S, Klein HU, Hall WJ, Brown MW, Goldberger JJ, Goldstein RE, Schuger C, Zareba W, Daubert JP. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT. Eur Heart J. 2011;32: 1622-1630. doi: 10.1093/eurheartj/ehq407.
6. Peterson PN, Greiner MA, Qualls LG, Al-Khatib SM, Curtis JP, Fonarow GC, Hammill SC, Heidenreich PA, Hammill BG, Piccini JP, Hernandez AF, Curtis LH, Masoudi FA. QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy. JAMA. 2013;310: 617-626. doi: 10.1001/jama.2013.8641.
7. Muto C, Gasparini M, Iacopino S, Peraldo C, Curnis A, Sassone B, Diotallevi P, Davinelli M, Valsecchi S, Tuccillo B. Efficacy of LOw-dose DObutamine stress-echocardiography to predict cardiac resynchronization therapy response (LODO-CRT) multicenter prospective study: Design and rationale. Am Heart J. 2008;156: 656-661. doi: 10.1016/j. ahj.2008.06.011.
8. Lopez-Andrès N, Rossignol P, Iraqi W, Fay R, Nuée J, Ghio S, Cleland JG, Zannad F, Lacolley P. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: Insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail. 2012;14: 74-81. doi: 10.1093/eurjhf/hfr151.
9. Zampetaki A, Mayr M. MicroRNAs in vascular and metabolic disease. Circ Res. 2012;110: 508-522. doi: 10.1161/CIRCRESAHA.111.247445.
10. Montgomery RL, Hullinger TG, Semus HM, Dickinson BA, Seto AG, Lynch JM, Stack C, Latimer PA, Olson EN, van Rooij E. Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation. 2011;124: 1537-1547. doi: 10.1161/CIRCULATIONAHA.111.030932.
11. Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S, Leierseder S, Loyer X, Giacca M, Zentilin L, Thum T, Laggerbauer B, Engelhardt S. MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation. 2013;127: 2097-2106. doi: 10.1161/CIRCULATIONAHA.112.000882.
12. Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: Novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110: 483-495. doi: 10.1161/CIRCRESAHA.111.247452.
13. Zhu H, Fan GC. Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis. 2011;1: 138-149.
14. Das S, Aiba T, Rosenberg M, Hessler K, Xiao C, Quintero PA, Ottaviano FG, Knight AC, Graham EL, Boström P, Morissette MR, del Monte F, Begley MJ, Cantley LC, Ellinor PT, Tomaselli GF, Rosenzweig A. Pathological role of serum-and glucocorticoid-regulated kinase 1 in adverse ventricular remodeling. Circulation. 2012;126: 2208-2219. doi: 10.1161/CIRCULATIONAHA.112.115592.
15. Zhuang J, Yamada KA, Saffitz JE, Kléber AG. Pulsatile stretch remodels cell-to-cell communication in cultured myocytes. Circ Res. 2000;87: 316-322.
16. Waldenström A, Gennebäck N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One. 2012;7: E34653. doi: 10.1371/journal.pone.0034653.
17. Taminau J, Steenhoff D, Coletta A, Meganck S, Lazar C, de Schaetzen V, Duque R, Molter C, Bersini H, Nowé A, Weiss Solís DY. inSilicoDb: An R/Bioconductor package for accessing human Affymetrix expert-curated datasets from GEO. Bioinformatics. 2011;27: 3204-3205. doi: 10.1093/bioinformatics/btr529.
18. Wettenhall JM, Smyth GK. limmaGUI: A graphical user interface for linear modeling of microarray data. Bioinformatics. 2004;20: 3705-3706. doi: 10.1093/bioinformatics/bth449.
19. Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 2004;32(database issue): D109-D111. doi: 10.1093/nar/gkh023.
20. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120: 15-20. doi: 10.1016/j.cell.2004.12.035.
21. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res. 2009;37(database issue): D155-D158. doi: 10.1093/nar/gkn809.
22. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med. 1990;9: 811-818.
23. Tijsen AJ, Pinto YM, Creemers EE. Circulating microRNAs as diagnostic biomarkers for cardiovascular diseases. Am J Physiol Heart Circ Physiol. 2012;303: H1085-H1095. doi: 10.1152/ajpheart.00191.2012.
24. Wang YT, Tsai PC, Liao YC, Hsu CY, Juo SH. Circulating microRNAs have a sex-specific association with metabolic syndrome. J Biomed Sci. 2013;20: 72. doi: 10.1186/1423-0127-20-72.
25. Dupont M, Rickard J, Baranowski B, Varma N, Dresing T, Gabi A, Finucan M, Mullens W, Wilkoff BL, Tang WH. Differential response to cardiac resynchronization therapy and clinical outcomes according to QRS morphology and QRS duration. J Am Coll Cardiol. 2012;60: 592-598. doi: 10.1016/j.jacc.2012.03.059.
26. Spragg DD, Leclercq C, Loghmani M, Faris OP, Tunin RS, DiSilvestre D, McVeigh ER, Tomaselli GF, Kass DA. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108: 929-932. doi: 10.1161/01.CIR.0000088782.99568.CA.
27. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: Potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12: 1681-1692.
28. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. Akt1 is required for physiological cardiac growth. Circulation. 2006;113: 2097-2104. doi: 10.1161/CIRCULATIONAHA.105.595231.
29. Matsui T, Li L, Wu JC, Cook SA, Nagoshi T, Picard MH, Liao R, Rosenzweig A. Phenotypic spectrum caused by transgenic overexpression of activated Akt in the heart. J Biol Chem. 2002;277: 22896-22901. doi: 10.1074/jbc.M200347200.
30. Barth AS, Aiba T, Halperin V, DiSilvestre D, Chakir K, Colantuoni C, Tunin RS, Dimaano VL, Yu W, Abraham TP, Kass DA, Tomaselli GF. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circ Cardiovasc Genet. 2009;2: 371-378. doi: 10.1161/CIRCGENETICS.108.832345.
31. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, Reczko M, Gerangelos S, Koziris N, Dalamagas T, Hatzigeorgiou AG. TarBase 6.0: Capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res. 2012;40(database issue): D222-D229. doi: 10.1093/nar/gkr1161.
32. Tang X, Muniappan L, Tang G, Ozcan S. Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription. RNA. 2009;15: 287-293. doi: 10.1261/rna.1211209.
33. Chakir K, Daya SK, Tunin RS, Helm RH, Byrne MJ, Dimaano VL, Lardo AC, Abraham TP, Tomaselli GF, Kass DA. Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation. 2008;117: 1369-1377. doi: 10.1161/CIRCULATIONAHA.107.706291.
34. Khan FZ, Virdee MS, Palmer CR, Pugh PJ, O'Halloran D, Elsik M, Read PA, Begley D, Fynn SP, Dutka DP. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: The TARGET study: A randomized, controlled trial. J Am Coll Cardiol. 2012;59: 1509-1518. doi: 10.1016/j.jacc.2011.12.030.
35. Heist EK, Taub C, Fan D, Arzola-Castaner D, Alabiad CR, Reddy VY, Mansour M, Mela T, Picard MH, Ruskin JN, Singh JP. Usefulness of a novel "response score" to predict hemodynamic and clinical outcome from cardiac resynchronization therapy. Am J Cardiol. 2006;97: 1732-1736. doi: 10.1016/j.amjcard.2006.01.035.